Typologization of russian regions as per environmental factors, factors related to educational process and schoolchildren’s health

Por S.V. Kleyn, D.A. Eisfeld, N.V. Nikiforova
Publicado em 2021-12-01

Systemic Inflammatory Response in Brain Injury

Por D. V. Vyalov, N. V. Nikiforova, Yu. A. Churlyaev
Publicado em 2007-12-01

On issues related to national risk-based system for control over food products distributed on the market

Por N.V. Zaitseva, I.V. May, D.А. Kiryanov, V.М. Chigvintsev, N.V. Nikiforova
Publicado em 2021-12-01

Development of Central Diabetes Insipidus in a Female Victim with Severe Brain Injury

Por N. V. Nikiforova, I. K. Ratkin, Yu. A. Churlyaev, R. S. Turygin, S. V. Arkhipova, G. N. Averchinkova
Publicado em 2009-10-01

Endogenous Intoxication in Pulmonary Complications in Patients with Severe Brain Injury

Por N. N. Yepifantseva, T. I. Borshchikova, Yu. A. Churlyaev, D. G. Dantsiger, N. V. Nikiforova, L. G. Kheringson
Publicado em 2008-06-01

Oxidant-Antioxidant Balance in Severe Brain Injury

Por N. N. Yepifantseva, T. I. Borshchikova, Yu. A. Churlyaev, I. K, Ratkin, N. V. Nikiforova, S. A. KlochkovaAbelyants, L. G. Kheringson
Publicado em 2010-02-01

Proteins of the Hageman Factor System in an Inflammatory Reaction in the Acute Period of Severe Brain Injury

Por T. I. Borshchikova, N. N Yepifantseva, Yu. A. Churlyaev, N. V., Nikiforova, Ya. A. Zhukova, A. I. Pirogova, Ye. A. Nikitina, A. V. Yekimovskikh
Publicado em 2010-08-01

Serum Markers of Apoptosis in Traumatic and Ischemic Brain Injury

Por N. N. Yepifantseva, T. I. Borshchikova, P. G. Sitnikov, Yu. A. Churlyaev, I. K, Ratkin, N. V. Nikiforova, G. S. Surzhikova, S. A. Klochkova-Abelyants, G. N. Averchenkova
Publicado em 2009-12-01

Impact of interleukin-10 and interleukin-28 gene polymorphisms on the development and course of lupus nephritis

Por T N Krasnova, L M Samokhodskaya, L V Ivanitsky, A D Korogodina, E N Borisov, N V Nikiforova, P I Novikov, A A Kamalov, N A Mukhin
Publicado em 2015-06-01

Severe adverse events from treatment with genetically engineered biological agents in patients with rheumatic diseases

Por S V Moiseev, P I Novikov, E N Semenkova, L A Strizhakov, S V Guliaev, T N Ianushkevich, N V Nikiforova, A D Meshkov, V V Panasiuk, Iu D Sorokin, M V Taranova, S A Parfenova, L V Dubrovskaia, E S Zhabina, E I Kuznetsova, I A Lopatina, N M Bulanov, N A Mukhin
Publicado em 2013-05-01

Evaluation of the short-term efficacy and safety of biological agents in different rheumatic diseases: a multidisciplinary therapeutic hospital"s experience

Por N A Mukhin, P I Novikov, Sergey Valentinovich Moiseev, T M Ignatova, L V Kozlovskaya, E N Semenkova, V V Fomin, S V Gulyaev, T N Krasnova, L A Strizhakov, T N Yanushkevich, V V Panasyuk, N V Nikiforova, S V Roshchupkina, Yu D Sorokin, A D Meshkov, L V Dubrovskaya, E S Zhabina, S A Parfenova, E I Kuznetsova, I A Lopatina
Publicado em 2013-04-01